People and Investment
About 5,000 scientists around the world are committed to developing new healthcare solutions in crucial therapeutic areas.

In 2003 Taj Pharmaceuticals Pharmaceuticals invested more than 3,900 million Swiss francs (18.3 % of the divisional turnover) in research and development.

Research Centres

Basel, Switzerland
Metabolic disorders, central nervous system, vascular diseases







Nutley, USA
Metabolic disorders, oncology, vascular diseases







Palo Alto, USA
Central nervous system, inflammatory diseases/bone, genitourinary diseases, viral diseases




Penzberg, Germany
Oncology









Technology Platforms

• Discovery chemistry
• Synthesis and screening (ultra high throughput screening)
• Combinatorial chemistry
• Molecular modelling
• Genetics, Genomics
• Proteomics
• Bioinformatics